Coutts SM - Search Results

1

Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects.

Kandiah DA, Sali A, Sheng Y, Victoria EJ, Marquis DM, Coutts SM, Krilis SA. Kandiah DA, et al. Among authors: coutts sm. Adv Immunol. 1998;70:507-63. doi: 10.1016/s0065-2776(08)60393-4. Adv Immunol. 1998. PMID: 9755344 Review.

2

Structural characterization and optimization of antibody-selected phage library mimotopes of an antigen associated with autoimmune recurrent thrombosis.

Sem DS, Baker BL, Victoria EJ, Jones DS, Marquis D, Yu L, Parks J, Coutts SM. Sem DS, et al. Among authors: coutts sm. Biochemistry. 1998 Nov 17;37(46):16069-81. doi: 10.1021/bi9807207. Biochemistry. 1998. PMID: 9819200

3

The structure-activity relationships of a series of suicide inhibitors of phospholipase A2.

Yu L, Ternansky RJ, Victoria EJ, Chang J, Coutts SM. Yu L, et al. Among authors: coutts sm. Bioorg Med Chem Lett. 1998 Aug 18;8(16):2129-32. doi: 10.1016/s0960-894x(98)00378-3. Bioorg Med Chem Lett. 1998. PMID: 9873499

4

Multivalent thioether-peptide conjugates: B cell tolerance of an anti-peptide immune response.

Jones DS, Coutts SM, Gamino CA, Iverson GM, Linnik MD, Randow ME, Ton-Nu HT, Victoria EJ. Jones DS, et al. Among authors: coutts sm. Bioconjug Chem. 1999 May-Jun;10(3):480-8. doi: 10.1021/bc9801373. Bioconjug Chem. 1999. PMID: 10346881

5

Carbonothioate phospholipids as substrate for a spectrophotometric assay of phospholipase A2.

Yu L, Ternansky RJ, Crisologo JF, Chang J, Baker BL, Coutts SM. Yu L, et al. Among authors: coutts sm. Anal Biochem. 1998 Dec 1;265(1):35-41. doi: 10.1006/abio.1998.2887. Anal Biochem. 1998. PMID: 9866705

6

Object-oriented approach to drug design enabled by NMR SOLVE: first real-time structural tool for characterizing protein-ligand interactions.

Sem DS, Yu L, Coutts SM, Jack R. Sem DS, et al. Among authors: coutts sm. J Cell Biochem Suppl. 2001;Suppl 37:99-105. doi: 10.1002/jcb.10070. J Cell Biochem Suppl. 2001. PMID: 11842434 Review.

7

Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolbox.

Sem DS, Bertolaet B, Baker B, Chang E, Costache AD, Coutts S, Dong Q, Hansen M, Hong V, Huang X, Jack RM, Kho R, Lang H, Ma CT, Meininger D, Pellecchia M, Pierre F, Villar H, Yu L. Sem DS, et al. Chem Biol. 2004 Feb;11(2):185-94. doi: 10.1016/j.chembiol.2004.02.012. Chem Biol. 2004. PMID: 15123280

8

Conjugates of double-stranded oligonucleotides with poly(ethylene glycol) and keyhole limpet hemocyanin: a model for treating systemic lupus erythematosus.

Jones DS, Hachmann JP, Osgood SA, Hayag MS, Barstad PA, Iverson GM, Coutts SM. Jones DS, et al. Among authors: coutts sm. Bioconjug Chem. 1994 Sep-Oct;5(5):390-9. doi: 10.1021/bc00029a003. Bioconjug Chem. 1994. PMID: 7849067

9

Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists.

Musser JH, Chakraborty UR, Sciortino S, Gordon RJ, Khandwala A, Neiss ES, Pruss TP, Van Inwegen R, Weinryb I, Coutts SM. Musser JH, et al. Among authors: coutts sm. J Med Chem. 1987 Jan;30(1):96-104. doi: 10.1021/jm00384a017. J Med Chem. 1987. PMID: 3806607

10

Pharmacological intervention in antibody mediated disease.

Coutts SM, Plunkett ML, Iverson GM, Barstad PA, Berner CM. Coutts SM, et al. Lupus. 1996 Apr;5(2):158-9. doi: 10.1177/096120339600500214. Lupus. 1996. PMID: 8743132 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters